Oncotype Dx DCIS Test

Advanced genomic testing to evaluate recurrence risk in DCIS and guide personalised treatment decisions

Call: 9240299624

Get a CALLBACK from our
Health Advisor

Click to Upload

I authorize Max@home representative to contact/WhatsApp me.

Call: 9240299624

Comprehensive Oncotype DX DCIS Testing

MAX@Home offers the Oncotype DX DCIS Test, a genomic test that helps doctors assess the risk of cancer recurrence in patients with DCIS (Ductal Carcinoma In Situ). The results help decide if radiation therapy is needed after surgery.

Key Highlights

Precise recurrence risk analysis
Clinically supervised and safe testing
Trusted expertise from MAX@Home

What is the Oncotype DX DCIS Test?

The Oncotype DX DCIS test is for patients with ductal carcinoma in situ, an early type of breast cancer. It looks at gene activity in the tumor to estimate the risk of cancer returning and helps doctors choose the best treatment after surgery.

Who Should Consider the Oncotype DX DCIS Test?

Women diagnosed with Stage 0 breast cancer (DCIS)
Patients who have undergone lumpectomy or breast-conserving surgery
Individuals who want to understand their recurrence risk
Patients seeking clarity about whether radiation therapy is necessary
Those looking for convenient, coordinated genomic testing support

Procedure for the Oncotype DX DCIS Test

Eligibility Review
Healthcare professionals check your medical history and pathology reports to make sure you are eligible for the cancer test.
Sample Collection
A sample of your preserved tumor tissue is collected from the hospital or pathology lab.
Genomic Analysis
The sample is tested using genomic technology to check certain gene patterns.
Report Generation
A detailed report with your DCIS score is prepared and sent to your doctor.
Doctor Consultation
Your oncologist will go over the results with you and talk about the best treatment plan.

Why Choose MAX@Home for the Oncotype DX DCIS Test?

Comfort & Convenience
We arrange to collect your tissue sample from the hospital or lab, so you do not have to travel. This makes the process easier for you.
Doctor-Guided Care
Our oncology experts support you at every step to make sure your results are understood correctly and your treatment plan fits your needs.
Clinically Trusted Testing
The Oncotype DX DCIS Test is trusted by doctors around the world and is often used to help make treatment decisions based on solid evidence.
End-to-End Coordination
We handle everything, from paperwork to talking with the lab, so your experience is smooth and stress-free.

Understanding Oncotype DX DCIS Score Results

The DCIS score ranges from 0 to 100 and shows the chance of cancer coming back in the same breast within 10 years after breast-conserving surgery.

DCIS Score Range	Risk Level	Meaning	Treatment Insight
0–38	Low Risk	Low chance of recurrence	Radiation therapy may not be necessary; monitoring or hormonal therapy may be advised
39–54	Intermediate Risk	Moderate recurrence risk	Doctors evaluate whether radiation therapy would be beneficial
55–100	High Risk	Higher chance of recurrence	Radiation therapy is more likely to be recommended

Key Notes

Lower scores suggest a reduced risk and may help avoid unnecessary radiation therapy.
Intermediate scores require personalised treatment decisions.
Higher scores indicate greater recurrence risk and a stronger likelihood that radiation therapy will be advised.

Important: Results should always be interpreted by an oncologist along with age, tumor size, and pathology findings.

Schedule Your Oncotype DX DCIS Test Now

MAX@Home provides advanced Oncotype DX DCIS testing with expert coordination, secure tissue handling, and professional oncology guidance throughout the process. Contact the care team to schedule your test and receive personalised assistance.